The Neurokinin-1 Receptor Antagonist Orvepitant Is A Novel Anti-Tussive Therapy For Chronic Refractory Cough: Results From A Phase 2 Study (volcano-1) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Smith, JA
  • Allman, D
  • Badri, H
  • Miller, R
  • Morris, J
  • Satia, Imran
  • Wood, A
  • Trower, M

publication date

  • January 1, 2017